Literature DB >> 1694117

Reactivity of human monoclonal IgM with nerve glycosphingolipids.

B Hauttecoeur1, C Schmitt, C Dubois, F Danon, J C Brouet.   

Abstract

We examined the reactivity of monoclonal IgM of sera from patients with neuropathy and monoclonal IgM, with or without antibody activity to myelin-associated glycoprotein (MAG), as well as sera from non-neurologic patients with Waldenström's macroglobulinaemia, with various nerve glycolipids extracts or with purified gangliosides. As expected from previous studies, all (five cases) anti-MAG IgM stained two glycolipids, the chemical characteristics of which corresponded to sulphated glucuronyl-paragloboside (SGPG) and sulphated glucuronyl-lactosaminyl-paragloboside (SGLPG). Five of 12 sera from patients with neuropathy whose IgM was devoid of anti-MAG reactivity stained nerve extracts greatly enriched (98%) with SGPG and SGLPG. Three of these five sera reacted with additional glycolipids and/or gangliosides. Two of 16 sera from patients with macroglobulinaemia without neuropathy reacted strongly with both SGPG and SGLPG. The latter finding as well as the detection of low titre of anti-sphingolipid antibodies in normal sera may cast a doubt on the pathogenetic significance of this antibody activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1694117      PMCID: PMC1535280          DOI: 10.1111/j.1365-2249.1990.tb05230.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method.

Authors:  L SVENNERHOLM
Journal:  Biochim Biophys Acta       Date:  1957-06

2.  Neuropathy and IgM paraproteinemia: differential binding of IgM M-proteins to peripheral nerve glycolipids.

Authors:  S Kusunoki; T Kohriyama; A R Pachner; N Latov; R K Yu
Journal:  Neurology       Date:  1987-11       Impact factor: 9.910

Review 3.  Peripheral neuropathy associated with monoclonal IgM autoantibody.

Authors:  A J Steck; N Murray; K Dellagi; J C Brouet; M Seligmann
Journal:  Ann Neurol       Date:  1987-12       Impact factor: 10.422

4.  Sulfated glucuronyl glycolipids reacting with anti-myelin-associated glycoprotein monoclonal antibodies including IgM paraproteins in neuropathy: species distribution and partial characterization of epitopes.

Authors:  A A Ilyas; M C Dalakas; R O Brady; R H Quarles
Journal:  Brain Res       Date:  1986-10-15       Impact factor: 3.252

5.  Antibodies to sulfated glucuronic acid containing glycosphingolipids in neuropathy associated with anti-MAG antibodies and in normal subjects.

Authors:  S McGinnis; T Kohriyama; R K Yu; M A Pesce; N Latov
Journal:  J Neuroimmunol       Date:  1988-01       Impact factor: 3.478

6.  Heterogeneity of human anti-MAG IgM as revealed by their reactivity on avian embryonic tissues.

Authors:  G C Tucker; K Dellagi; C Schmitt; J C Brouet; J P Thiery
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

7.  Isolation and characterization of a trisialoganglioside from mouse brain, containing 9-O-acetyl-N-acetylneuraminic acid.

Authors:  R Ghidoni; S Sonnino; G Tettamanti; N Baumann; G Reuter; R Schauer
Journal:  J Biol Chem       Date:  1980-07-25       Impact factor: 5.157

8.  Monoclonal IgM in a patient with paraproteinemic polyneuropathy binds to gangliosides containing disialosyl groups.

Authors:  A A Ilyas; R H Quarles; M C Dalakas; P H Fishman; R O Brady
Journal:  Ann Neurol       Date:  1985-12       Impact factor: 10.422

9.  Gangliosides GM2, IV4GalNAcGM1b, and IV4GalNAcGC1a as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy.

Authors:  A A Ilyas; S C Li; D K Chou; Y T Li; F B Jungalwala; M C Dalakas; R H Quarles
Journal:  J Biol Chem       Date:  1988-03-25       Impact factor: 5.157

10.  Characterization of sulfated glucuronic acid containing glycolipids reacting with IgM M-proteins in patients with neuropathy.

Authors:  T Ariga; T Kohriyama; L Freddo; N Latov; M Saito; K Kon; S Ando; M Suzuki; M E Hemling; K L Rinehart
Journal:  J Biol Chem       Date:  1987-01-15       Impact factor: 5.157

View more
  5 in total

1.  A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group.

Authors:  X Mariette; C Chastang; P Clavelou; J P Louboutin; J M Leger; J C Brouet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

2.  Peripheral neuropathy associated with monoclonal IgM antibody to glycolipids with a terminal glucuronyl-3-sulfate epitope.

Authors:  P Fredman; J Lycke; O Andersen; M Vrethem; J Ernerudh; L Svennerholm
Journal:  J Neurol       Date:  1993-06       Impact factor: 4.849

3.  Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. IgM-associated Polyneuropathy Study Group.

Authors:  E Oksenhendler; S Chevret; J M Léger; J P Louboutin; A Bussel; J C Brouet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

4.  Monoclonal IgM from patients with peripheral demyelinating neuropathies cross-react with bacterial polypeptides.

Authors:  J C Brouet; X Mariette; M C Gendron; M L Dubreuil
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

Review 5.  Can antiglycolipid antibodies present in HIV-infected individuals induce immune demyelination?

Authors:  S Petratos; M E Gonzales
Journal:  Neuropathology       Date:  2000-12       Impact factor: 1.906

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.